TABLE 2.

Difference among Day1, Day2,and Day5 time points for serum MMP-9 and BNDF levels for AIS patients in the good and poor prognosis groups.

	MMP-9 (ng/mL)			BDNF (ng/mL)
	Day1	Day2	Day5	Day1	Day2	Day5
Good prognosis (n = 24)	67.22 ± 19.72	62.75 ± 20.67	55.23 ± 18.11	4.64 ± 3.32	6.22 ± 2.72	8.55 ± 2.90
Poor prognosis (n = 18)	72.93 ± 21.80	75.23 ± 22.50	79.82 ± 20.55ΔΔ	7.24 ± 1.70ΔΔ	5.77 ± 3.11	4.32 ± 3.42ΔΔ
Groups effect	F = 5.258, P = 0.027, η2P = 0.116			F = 0.618, P = 0.436, η2P = 0.015
Time effect	F = 2.236, P = 0.113, η2P = 0.053			F = 3.428, P = 0.049, η2P = 0.079
Interaction	F = 31.244, P < 0.001, η2P = 0.439			F = 133.954, P < 0.001, η2P = 0.770

Data represent as mean ± SD, P-values denote a significant difference between groups determined by one-way ANOVA, while “^ΔΔ” denotes a significant difference compared with the good prognosis group under simple-effect analysis (^ΔΔP ≤ 0.01).